BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22168621)

  • 1. Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.
    Zhang X; Li N; Li X; Zhao W; Qiao Y; Liang L; Ding Y
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1117-25. PubMed ID: 22168621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
    Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
    J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of formin-like 2 predicts poor prognosis in hepatocellular carcinoma.
    Liang L; Guan J; Zeng Y; Wang J; Li X; Zhang X; Ding Y
    Hum Pathol; 2011 Nov; 42(11):1603-12. PubMed ID: 21496865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
    Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
    Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of ZBP-89 and its prognostic significance in hepatocellular carcinoma.
    Zhang CZ; Cao Y; Yun JP; Chen GG; Lai PB
    Histopathology; 2012 Jun; 60(7):1114-24. PubMed ID: 22372401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CC chemokine receptor 6 expression predicts poor prognosis in hepatocellular carcinoma.
    Liu F; Lv H; Jia X; Liu G; Li T; Xu Z; Li J
    J Surg Oncol; 2014 Aug; 110(2):151-5. PubMed ID: 24634224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
    Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
    Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
    Chen S; Wang L; Yao B; Liu Q; Guo C
    Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.
    He C; Xu J; Zhang J; Xie D; Ye H; Xiao Z; Cai M; Xu K; Zeng Y; Li H; Wang J
    Hum Pathol; 2012 Sep; 43(9):1425-35. PubMed ID: 22406368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo.
    Fang F; Yang L; Tao Y; Qin W
    Cancer; 2012 Jan; 118(1):134-46. PubMed ID: 21713761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Romo1 promotes production of reactive oxygen species and invasiveness of hepatic tumor cells.
    Chung JS; Park S; Park SH; Park ER; Cha PH; Kim BY; Chung YM; Woo SR; Han CJ; Kim SB; Suh KS; Jang JJ; Lee K; Choi DW; Lee S; Lee GY; Hahm KB; Shin JA; Kim BS; Noh KH; Kim TW; Lee KH; Yoo YD
    Gastroenterology; 2012 Oct; 143(4):1084-94.e7. PubMed ID: 22749933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.
    Ke Q; Ji J; Cheng C; Zhang Y; Lu M; Wang Y; Zhang L; Li P; Cui X; Chen L; He S; Shen A
    Exp Mol Pathol; 2009 Dec; 87(3):167-72. PubMed ID: 19686732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.
    Li X; Wang J; Zhang X; Zeng Y; Liang L; Ding Y
    Ann Surg Oncol; 2012 Jan; 19(1):145-53. PubMed ID: 21861235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.
    Yu B; Yang X; Xu Y; Yao G; Shu H; Lin B; Hood L; Wang H; Yang S; Gu J; Fan J; Qin W
    J Hepatol; 2009 May; 50(5):948-57. PubMed ID: 19303159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.
    Morinaga S; Nakamura Y; Ishiwa N; Yoshikawa T; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S
    Oncol Rep; 2004 Dec; 12(6):1189-94. PubMed ID: 15547736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC.
    Yi Y; Wu H; Gao Q; He HW; Li YW; Cai XY; Wang JX; Zhou J; Cheng YF; Jin JJ; Fan J; Qiu SJ
    Ann Surg Oncol; 2013 Jan; 20(1):267-76. PubMed ID: 22805863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma.
    Ding ZB; Shi YH; Zhou J; Shi GM; Ke AW; Qiu SJ; Wang XY; Dai Z; Xu Y; Fan J
    Cancer; 2009 Oct; 115(20):4753-65. PubMed ID: 19626651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.